Results for Fragment based drug design
-
vlifesciences.com
Computer aided molecular design, drug design, QSAR, Molecular Modeling Software
Computer aided molecular design and drug design company offering Molecular docking, QSAR, 2D QSAR, 3D QSAR, Molecular modeling, Homology modeling, Fragment based drug design, Docking software, Combinatorial library generation, Virtual screening, Ligand sc
-
erictbaldwin.com
structure based consulting, Drug Discovery Consulting Upper Holland, PA Home
Consultant and Broker for Biophysical and Structural Services gene-to-protein, X-ray gene-to-structure, fragment based drug design,computational methods
-
chemelian.com
Chemelian
Chemelian is an early-stage drug discovery company focused on the treatment of cancer, macular degeneration (AMD), and diabetic macular edema (DME). Chemelian's Founder, Dr. Ian L. Scott, is the principal inventor of three clinical candidates: Emixustat
-
freshdirectionsconsulting.com
FRESH Directions Consulting, LLC - Home
Copyright (C) 2007 FRESH Directions Consulting, LLC
-
chemelian.org
Chemelian
Chemelian is an early-stage drug discovery company focused on the treatment of cancer, macular degeneration (AMD), and diabetic macular edema (DME). Chemelian's Founder, Dr. Ian L. Scott, is the principal inventor of three clinical candidates: Emixustat
-
Computer aided molecular design, drug design, QSAR, Molecular Modeling Software
Computer aided molecular design and drug design company offering Molecular docking, QSAR, 2D QSAR, 3D QSAR, Molecular modeling, Homology modeling, Fragment based drug design, Docking software, Combinatorial library generation, Virtual screening, Ligand sc
-
sprintbioscience.com
Sprint Bioscience | fragment-based gene-to-lead
A fully equipped platform for fragment-based drug discovery comprising protein expression and purification, fragment screening, high-throughput X-ray
-
structure based consulting, Drug Discovery Consulting Upper Holland, PA Home
Consultant and Broker for Biophysical and Structural Services gene-to-protein, X-ray gene-to-structure, fragment based drug design,computational methods
-
zobio.com
ZoBio - Drug Discovery Technology |
ZoBio offers Fragment-Based Drug Discovery research services on a fee-for-service basis to customers across the pharmaceutical & biotechnology industries.
-
Chemelian
Chemelian is an early-stage drug discovery company focused on the treatment of cancer, macular degeneration (AMD), and diabetic macular edema (DME). Chemelian's Founder, Dr. Ian L. Scott, is the principal inventor of three clinical candidates: Emixustat
-
FRESH Directions Consulting, LLC - Home
Copyright (C) 2007 FRESH Directions Consulting, LLC
-
Chemelian
Chemelian is an early-stage drug discovery company focused on the treatment of cancer, macular degeneration (AMD), and diabetic macular edema (DME). Chemelian's Founder, Dr. Ian L. Scott, is the principal inventor of three clinical candidates: Emixustat
-
gene-to-lead.com
Gene 2 Lead powered by Sprint Bioscience
Offers research service based on fast and efficient fragment based methods for lead generation. | FBDD – A route for fast development of new drugs.
-
gene2lead.com
Gene 2 Lead powered by Sprint Bioscience
Offers research service based on fast and efficient fragment based methods for lead generation. | FBDD – A route for fast development of new drugs.
-
genetolead.com
Gene 2 Lead powered by Sprint Bioscience
Offers research service based on fast and efficient fragment based methods for lead generation. | FBDD – A route for fast development of new drugs.
2 websites blocked by safe search filter.
